Skip to main content
Funded Studies

Omar El-Agnaf, PhD

Professor at Neurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalif

Dr. Omar El-Agnaf is currently the acting executive director of the Qatar Biomedical Research Institute, the director of the Neurological Disorders Research Center at the same institute, and a professor at Hamad Bin Khalifa University at the Qatar Foundation in Doha. Dr. El-Agnaf is considered a pioneer in the field of Parkinson's disease (PD) and related disorders. His discoveries have greatly impacted the scientific research community, by providing further insight into the molecular pathogenesis of PD and by offering new opportunities for the development of novel diagnostic and therapeutic tools. Dr. El-Agnaf's findings have translated into clinical studies to evaluate the potential use of alpha-synuclein (the sticky protein that clumps in the brain of those with PD) in body fluids as a diagnostic marker for PD and related disorders; in addition, his research has produced several inventions. Dr. El-Agnaf has published basic and translational research in high-ranking scientific journals.


Associated Grants

  • Exploring the Use of Alpha-synuclein Assays for Translational Biomarkers and Pharmaceutical Intervention Trials

    2017


  • Alpha-Synuclein Assay Standardization LEAPS

    2014


  • Testing Novel Compounds for Noninvasive Delivery of Small Interfering RNA into CNS

    2011


  • Validation of alpha-synuclein oligomers as biomarker for Parkinson’s disease

    2011


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.